Explore our blog
Mechanism of Action: Step Up & Be Heard in Rare Disease
In a crowded market, your drug’s mechanism of action (MOA) is more than a scientific formality – it’s strategic....
Allowing Access Versus Driving Access: A New Challenge for Health Systems
Author: Kelly Gaffney, PharmD, BCOP, DPLA, Senior Director, Access Experience Team